Voltage-gated T-type Ca2+ channels and heart failure.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Proceedings of the Association of American Physicians

• Publication date

  1999-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/PAA.1999.111.5.429PMID 10519164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increases of T-type Ca2+ current in heart cells of the cardiomyopathic hamster

  2004cited by this paper
• Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.

  1998cited by this paper
• Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.

  1998cited by this paper
• Molecular characterization of a neuronal low-voltage-activated T-type calcium channel

  1998cited by this paper
• Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.

  1997cited by this paper
• The clinical significance of neurohormonal activation.

  1997cited by this paper
• Ionic basis of ryanodine's negative chronotropic effect on pacemaker cells isolated from the sinoatrial node.

  1997cited by this paper
• Local angiotensin II and myocardial fibrosis.

  1997cited by this paper
• Mibefradil- and ω-conotoxin GVIA-induced inhibition of noradrenaline release from the sympathetic nerves of the human heart

  1997cited by this paper
• Increases of T-type Ca2+ current in heart cells of the cardiomyopathic hamster.

  1997cited by this paper
• The paracrine endothelin system: pathophysiology and implications in clinical medicine.

  1997cited by this paper
• The design of the Mortality Assessment in Congestive Heart Failure Trial (MACH-1, mibefradil).

  1997cited by this paper
• Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker.

  1997cited by this paper
• Low-voltage-activated T-type Ca2+ channels.

  1997cited by this paper
• The design of the Mortality Assessment in Congestive Heart Failure Trial (MACH-1, mibefradil).

  1997cited by this paper
• Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure.

  1997cited by this paper
• T-Type Ca2+ Channels and Pharmacological Blockade: Potential Pathophysiological Relevance

  1997cited by this paper
• Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats.

  1996cited by this paper
• Prevention of neointima formation by mibefradil after vascular injury in rats: Comparison with ACE inhibition

  1996cited by this paper
• Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.

  1996cited by this paper
• Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

  1996cited by this paper
• Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.

  1996cited by this paper
• Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure.

  1996cited by this paper
• Angiotensin II stimulates T-type Ca2+ channel currents via activation of a G protein, Gi.

  1996cited by this paper
• Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.

  1996cited by this paper
• ET‐1 Stimulates Ca2+ Currents in Cardiac Cells

  1995cited by this paper
• Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

  1995cited by this paper
• Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG.

  1995cited by this paper
• Biological determinants of aldosterone-induced cardiac fibrosis in rats.

  1995cited by this paper
• Selective inhibition of T-type Ca2+ channels by Ro 40-5967.

  1994cited by this paper
• The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.

  1994cited by this paper
• Effects of the calcium channel blockers, diltiazem and Ro 40–5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing‐induced heart failure

  1994cited by this paper
• Inhibition of Signal Ca2+ in Dog Coronary Arterial Vascular Muscle Cells by Ro 40–5967

  1994cited by this paper
• T-type calcium current in latent pacemaker cells isolated from cat right atrium.

  1994cited by this paper
• T-type Ca2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts.

  1994cited by this paper
• T-type calcium channels in adrenal glomerulosa cells: GTP-dependent modulation by angiotensin II.

  1993cited by this paper
• Effects of calcium channel blockade on the aortic intima in spontaneously hypertensive rats.

  1993cited by this paper
• Expression of voltage-gated calcium channels correlates with PDGF-stimulated calcium influx and depends upon cell density in C3H 10T1/2 mouse fibroblasts.

  1993cited by this paper
• Blocking T-type calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells.

  1993cited by this paper
• New synthetic ligands for L-type voltage-gated calcium channels.

  1993cited by this paper
• The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

  1993cited by this paper
• Ca2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts.

  1993cited by this paper
• T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes.

  1993cited by this paper
• Hemodynamic and humoral effects of the novel calcium antagonist Ro 40‐5967 in patients with hypertension

  1992cited by this paper
• The L type calcium current in single hypertrophied cardiomyocytes isolated from the right ventricle of ferret heart.

  1992cited by this paper
• Ro 40–5967, in Contrast to Diltiazem, Does Not Reduce Left Ventricular Contractility in Rats with Chronic Myocardial Infarction

  1991cited by this paper
• Increased negative inotropic effect of calcium-channel blockers in hypertrophied and failing rabbit heart.

  1991cited by this paper
• Calcium channels in vertebrate cells.

  1990cited by this paper
• The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts

  1990cited by this paper
• Multiple Types of Ca2+ Currents in Single Canine Purkinje Cells

  1989cited by this paper
• The effect of diltiazem on mortality and reinfarction after myocardial infarction.

  1989cited by this paper
• Characteristics of L- and T-type Ca2+ currents in canine cardiac Purkinje cells.

  1989cited by this paper
• Ca channels in adrenal glomerulosa cells: K+ and angiotensin II increase T-type Ca channel current.

  1988cited by this paper
• The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel.

  1988cited by this paper
• Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino‐atrial node cells.

  1988cited by this paper
• Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology

  1985cited by this paper
• The surprising heart: a review of recent progress in cardiac electrophysiology.

  1984cited by this paper

• Interaction studies between calmodulin and gating brake peptides from T-type channels

  2025cites this paper
• NRSF/REST-Mediated Epigenomic Regulation in the Heart: Transcriptional Control of Natriuretic Peptides and Beyond

  2022cites this paper
• The mineralocorticoid receptor leads to increased expression of EGFR and T-type calcium channels that support HL-1 cell hypertrophy

  2021cites this paper
• Insight into T-type calcium channel structure, function and modulation.

  2020cites this paper
• Differential expression of genes participating in cardiomyocyte electrophysiological remodeling via membrane ionic mechanisms and Ca2+-handling in human heart failure

  2019cites this paper
• Tetrodotoxin-sensitive Ca2+ Currents, but No T-type Currents in Normal, Hypertrophied, and Failing Mouse Cardiomyocytes

  2016cites this paper
• Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.

  2015cites this paper
• Small molecule and peptide therapies for chronic heart failure: a patent review (2011 – 2014)

  2015cites this paper
• Endostatin inhibits T-type Ca2+ channel current in guinea pig ventricular myocyte

  2015cites this paper
• Mechanisms of cardiovascular effects of oleanolic acid and related synthetic oleanane derivatives : an experimental study.

  2014cites this paper
• Transcriptional regulation of α1H T-type calcium channel under hypoxia.

  2014cites this paper
• Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker.

  2014cites this paper
• Investigating the homologue of the mammalian gene myocyte stress 1 in Drosophila melanogaster

  2013cites this paper
• Understanding the physiology of heart failure through cellular and in vivo models‐towards targeting of complex mechanisms

  2013cites this paper
• Electrophysiological Remodeling in Heart Failure

  2013cites this paper
• Role of NRSF/REST in the regulation of cardiac gene expression and function.

  2013cites this paper
• Calcium Channels As Therapeutic Targets

  2012cites this paper
• Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model

  2012cites this paper
• Transcriptional regulation of the fetal cardiac gene program.

  2012cites this paper
• Contribution of Sarcoplasmic Reticulum Ca2+ Release and Ca2+ Transporters on Sarcolemmal Channels to Ca2+ Transient in Fetal Mouse Heart

  2011cites this paper
• Actions of thalidomide in producing vascular relaxations.

  2010cites this paper
• Angiotensin II regulates endothelial cell migration through calcium influx via T‐type calcium channel in human umbilical vein endothelial cells

  2010cites this paper
• T-Type Ca2+ Channel Blockade Prevents Sudden Death in Mice With Heart Failure

  2009cites this paper
• Effects of Efonidipine Hydrochloride on Heart Rate and Circulatory Changes Due to Stress

  2009cites this paper
• Arrhythmia Mechanisms in the Failing Heart

  2008cites this paper
• Mechanisms of Disease: ion channel remodeling in the failing ventricle

  2008cites this paper
• T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.

  2008cites this paper
• Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core.

  2008cites this paper
• Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.

  2007cites this paper
• Calcium signaling phenomena in heart diseases: a perspective

  2007cites this paper
• A Molecular Determinant of Nickel Inhibition in Cav3.2 T-type Calcium Channels*

  2006cites this paper
• Cellular Functions and Fluxes of Calcium

  2006cites this paper
• Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396.

  2006cites this paper
• Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.

  2006cites this paper
• T-type channels-secretion coupling: evidence for a fast low-threshold exocytosis

  2006cites this paper
• Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development.

  2005cites this paper
• Pathophysiological significance of T-type Ca2+ channels: transcriptional regulation of T-type Ca2+ channel--regulation of CACNA1H by neuron-restrictive silencer factor.

  2005cites this paper
• T-Type Ca2+ Channels Are Involved in High Glucose–Induced Rat Neonatal Cardiomyocyte Proliferation

  2005cites this paper
• Ion channels as novel therapeutic targets in heart failure

  2005cites this paper
• Chapter 16 – Pharmacology of L-Type and T-Type Calcium Channels in the Heart

  2004cites this paper
• Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.

  2004cites this paper
• NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function

  2003influential citation
• Low-Voltage-Activated (“T-Type”) Calcium Channels in Review

  2003cites this paper
• Reversal of experimental neuropathic pain by T‐type calcium channel blockers

  2003cites this paper
• Calcium channels — basic aspects of their structure, function and gene encoding; anesthetic action on the channels — a review

  2002cites this paper
• Selectivity of different calcium antagonists on T- and L-type calcium currents in guinea-pig ventricular myocytes.

  2002cites this paper
• Identification and Localization of T-type Voltage-operated Calcium Channel Subunits in Human Male Germ Cells

  2002cites this paper
• High-throughput screening strategies for cardiac ion channels.

  2001cites this paper
• Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension

  2001cites this paper
• Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.

  2001cites this paper
• Inhibition of T‐Type and L‐Type Calcium Channels by Mibefradil: Physiologic and Pharmacologic Bases of Cardiovascular Effects

  2001cites this paper
• Evidence against an action of mibefradil at N-type voltage-operated calcium channels

  2001cites this paper